Corticosteroids and Anti TNF in Methotrexate Inadequate Responder Rheumatoid Arthritis Patient
Status:
Unknown status
Trial end date:
2014-09-01
Target enrollment:
Participant gender:
Summary
Compare the efficacy of adding small doses of prednisolone (10 mg) daily to the efficacy of
adding one of the available anti TNF in the treatment of methotrexate inadequate responder
rheumatoid arthritis patient.
Hypothesis:
Methotrexate + Prednisolone vs. Methotrexate + anti TNF